Phibro Animal Health (NASDAQ:PAHC) Upgraded by StockNews.com to Strong-Buy Rating

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a research report released on Wednesday.

A number of other brokerages have also recently weighed in on PAHC. Barclays increased their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $21.90 on Wednesday. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98. The firm’s 50-day simple moving average is $22.08 and its 200-day simple moving average is $21.48. The firm has a market cap of $886.95 million, a PE ratio of 50.93, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.12. The firm had revenue of $260.40 million for the quarter, compared to analysts’ expectations of $277.76 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. During the same quarter in the prior year, the firm posted $0.14 earnings per share. Equities analysts forecast that Phibro Animal Health will post 1.62 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.19%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.

Institutional Trading of Phibro Animal Health

Large investors have recently modified their holdings of the company. Quantbot Technologies LP bought a new position in Phibro Animal Health in the 3rd quarter worth about $70,000. nVerses Capital LLC acquired a new position in shares of Phibro Animal Health during the third quarter worth approximately $70,000. China Universal Asset Management Co. Ltd. grew its holdings in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares in the last quarter. CWM LLC increased its position in Phibro Animal Health by 190.8% in the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after acquiring an additional 4,175 shares during the period. Finally, Algert Global LLC bought a new stake in Phibro Animal Health during the 2nd quarter valued at $193,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.